Déprescription dans le contexte de l’hypertension [Deprescribing antihypertensive therapy]

Details

Serval ID
serval:BIB_5A2DC6BD14CF
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Déprescription dans le contexte de l’hypertension [Deprescribing antihypertensive therapy]
Journal
Revue medicale suisse
Author(s)
Tebib N., Wuerzner G.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
16/09/2020
Peer-reviewed
Oui
Volume
16
Number
706
Pages
1690-1692
Language
french
Notes
Publication types: Journal Article
Publication Status: ppublish
Abstract
With the rise of life-expectancy, the number of comorbidities can increase and lead to polypharmacy (≥ 5 drugs/day) and excessive polypharmacy (> 9 drugs/day). In order to define suitable therapeutic targets, it is essential to take into account the heterogeneity of this population which can be classified into 3 categories : robust, vulnerable or dependent. In this context, the concept of deprescription, which englobes the process of tapering or stopping drugs, aimed at improving patient outcomes, becomes an important therapeutic tool. In the context of hypertension, this approach seems to be a safe, provided that patients can benefit from regular monitoring. It must be considered in vulnerable and dependent patients or patients institutionalized in nursing homes. Although, scientific evidence slowly accumulates, its levels remain moderate. Finally, the deprescribing process, can also be applied in specifics situations in order to prevent adverse events, such as during a heat wave.
Keywords
Antihypertensive Agents/administration & dosage, Deprescriptions, Humans, Nursing Homes, Polypharmacy
Pubmed
Create date
19/09/2020 12:34
Last modification date
29/09/2020 6:26
Usage data